Recipient NameThomas J. Wilverding
- Central Admixture Pharmacy Services Inc
6800 Aston Street
Irvine, CA 92606
- Issuing Office:
- Division of Pharmaceutical Quality Operations IV
- (949) 608-2900
Dear Mr. Wilverding:
The U.S. Food and Drug Administration (FDA) has completed an evaluation of your firm’s corrective actions in response to our warning letter # 40-16, issued August 18, 2016. Based on our evaluation, it appears that you have adequately addressed the violations contained in this warning letter.
You are expected to take all necessary steps to ensure compliance with the Federal Food, Drug, and Cosmetic Act and FDA’s implementing regulations. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.
CDR Steven E. Porter, Jr.
Director, Division of Pharmaceutical Quality Operations IV